Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wellness Study of very low-dose escitalopram in chronic illness
ACTRN12608000398303Phase 4Terminated
- Sponsor
- Mood Research Foundation
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic condition comparing Escitalopram with Placebo (2 arms). Primary endpoints: Reduction in fatigue and Reduction in anxiety. Started Jul 2007; status: terminated.
02
Drugs
escitalopram
03
Conditions
chronic condition
Beyond the preview
Go deeper on ACTRN12608000398303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000398303.